Discover J&J
Medicines & therapies
Medical devices & technology
Discover J&J
Medicines & therapies
Medical devices & technology
Careers
Media
Contact
locationPlaceholder
Choose your country or region
Global
Global
English
North America
North America (Regional)
English
Canada
English
Français
United States
English
Asia Pacific
Asia Pacific (Regional)
English
Australia
English
China
中文
Hong Kong
English
中文
Japan
日本
Korea
한국어
New Zealand
English
Europe, Middle East & Africa (EMEA)
EMEA (Regional)
English
Middle East - Africa
الشرق الأوسط و أفريقيا (عربي)
Austria
Deutsch
Belgium
English
Français
Nederlands
Bulgaria
БЪЛГАРСКИ
Croatia
Hrvatski
Czech Republic
čeština
Denmark
Dansk
Estonia
English
Finland
Suomi
France
Français
Germany
Deutsch
Greece
ΕΛΛΗΝΙΚΑ
Hungary
Magyar
Ireland
English
Israel
עברית
Italy
Italiano
Latvia
English
Lithuania
English
Netherlands
Nederlands
Norway
Norsk
Poland
Polski
Portugal
Português
Romania
Română
Russia
Pусский
Serbia
Srpski
Slovakia
Slovenčina
Slovenia
Slovenščina
South Africa
English
Spain
Español
Switzerland
Français
Deutsch
Sweden
Svensk
Turkey
Türkçe
Ukraine
Україна
United Kingdom
English
Latin America
Latin America (Regional)
Español
Argentina
Español
Bolivia
Español
Brazil
Português
Central America and the Caribbean
Español
Chile
Español
Colombia
Español
Ecuador
Español
Mexico
Español
Paraguay
Español
Peru
Español
Uruguay
Español
Healthcare areas
Oncology
Immunology
Neuroscience
Cardiopulmonary
Products
Clinical trials
Pipeline
Patient resources
Innovative Medicine
healthcare areas
Menu
Healthcare areas
Oncology
Immunology
Neuroscience
Cardiopulmonary
Products
Clinical trials
Pipeline
Patient resources
Careers
Media
Contact
Show Search
Search Query
Clear
Submit Search
Dictate search request
Listening...
Search Results
No Results
See all results
Sorry, I don't understand. Please try again
Search Results
Search Query
Submit Search
Listening...
Dates
All (1137)
Last 7 days (5)
2024 (101)
2023 (76)
2022 (58)
2021 (67)
2020 (42)
2019 (68)
2018 (77)
2017 (80)
2016 (64)
Types
All (1137)
Article (57)
Page (7)
Press Release (1073)
There are 1,137 results that match your search.
Filters
Dates
All (1137)
Last 7 days (5)
2024 (101)
2023 (76)
2022 (58)
2021 (67)
2020 (42)
2019 (68)
2018 (77)
2017 (80)
2016 (64)
Types
All (1137)
Article (57)
Page (7)
Press Release (1073)
Relevance
Relevance
Newest
Oldest
Innovative Medicine
September 22, 2011
Health Canada Approves Expanded Indication For SIMPONI®* To Include Inhibition Of Structural Damage In The Treatment Of Moderately To Severely Active Rheumatoid Arthritis
SIMPONI® Indication Also Expanded To Include Improvement In Physical Function
Read more
Innovative Medicine
September 20, 2011
INCIVO® (Telaprevir) Approved In Europe Offering Higher Cure Rates For Genotype-1 Chronic Hepatitis C Compared To Standard Treatment
New treatment options increase chance of a cure
Read more
Innovative Medicine
September 15, 2011
24 Week Incivo® (Telaprevir)-Based Regimen Effective For Majority Of Previously Untreated Genotype-1 Chronic HCV Patients
ILLUMINATE Phase 3 Study Published In New England Journal Of Medicine
Read more
Innovative Medicine
September 14, 2011
Johnson & Johnson Symposium Honors 2011 Recipient Of The Dr. Paul Janssen Award For Biomedical Research
Ferrara Honored For Unlocking Key To Novel Anti-Angiogenesis Therapies
Read more
Innovative Medicine
September 9, 2011
FDA Issues Complete Response Letter To Janssen Biotech, Inc. for Simponi® Supplemental Biologics License Application
Read more
Innovative Medicine
September 8, 2011
FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation
Read more
Innovative Medicine
September 7, 2011
Zytiga® Approved In The European Union For Metastatic Castration-Resistant Prostate Cancer
First once-daily, oral treatment inhibits androgen production at all sources
Read more
Innovative Medicine
September 1, 2011
Young Patients To Benefit From Health Canada Approval Of Remicade®* For Treatment Of Pediatric Ulcerative Colitis
Canadian Children Six To 17 Years Old Become The First Worldwide To Benefit From A New Biologic Treatment Option Approved For Chronic Inflammatory Bowel Disease
Read more
Innovative Medicine
August 26, 2011
NUCYNTA® ER (Tapentadol Extended-Release Tablets) Receives FDA Approval For The Management Of Moderate To Severe Chronic Pain
Clinical Trial Data Demonstrate Efficacy, Safety and Favorable Tolerability
Read more
Research
August 4, 2011
Johnson & Johnson Pharmaceutical Research & Development Scientists Uncover Previously Unknown Role For Class Of Molecules
Read more
110 of 114
